Sorin Group S.p.A. Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Japan

TOKYO--(BUSINESS WIRE)--Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the Ministry of Health, Labor and Welfare (MHLW) approval to market the FACIL™ and REPLY™ families of dual and single chamber rate responsive pacemakers.

MORE ON THIS TOPIC